A phase II study of raltitrexed ('Tomudex') in patients with hepatocellular carcinoma

P. Rougier, M. Ducreux, D. Kerr, B. I. Carr, E. François, A. Adenis, L. Seymour

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)500-502
Number of pages3
JournalAnnals of Oncology
Volume8
Issue number5
DOIs
Publication statusPublished - May 1997

Keywords

  • Chemotherapy
  • Hepatocellular carcinoma
  • Raltitrexed
  • Tomudex
  • Treatment outcome

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Rougier, P., Ducreux, M., Kerr, D., Carr, B. I., François, E., Adenis, A., & Seymour, L. (1997). A phase II study of raltitrexed ('Tomudex') in patients with hepatocellular carcinoma. Annals of Oncology, 8(5), 500-502. https://doi.org/10.1023/A:1008249328792

A phase II study of raltitrexed ('Tomudex') in patients with hepatocellular carcinoma. / Rougier, P.; Ducreux, M.; Kerr, D.; Carr, B. I.; François, E.; Adenis, A.; Seymour, L.

In: Annals of Oncology, Vol. 8, No. 5, 05.1997, p. 500-502.

Research output: Contribution to journalArticle

Rougier, P, Ducreux, M, Kerr, D, Carr, BI, François, E, Adenis, A & Seymour, L 1997, 'A phase II study of raltitrexed ('Tomudex') in patients with hepatocellular carcinoma', Annals of Oncology, vol. 8, no. 5, pp. 500-502. https://doi.org/10.1023/A:1008249328792
Rougier P, Ducreux M, Kerr D, Carr BI, François E, Adenis A et al. A phase II study of raltitrexed ('Tomudex') in patients with hepatocellular carcinoma. Annals of Oncology. 1997 May;8(5):500-502. https://doi.org/10.1023/A:1008249328792
Rougier, P. ; Ducreux, M. ; Kerr, D. ; Carr, B. I. ; François, E. ; Adenis, A. ; Seymour, L. / A phase II study of raltitrexed ('Tomudex') in patients with hepatocellular carcinoma. In: Annals of Oncology. 1997 ; Vol. 8, No. 5. pp. 500-502.
@article{8bc22bed962b428193aca0194cc7276e,
title = "A phase II study of raltitrexed ('Tomudex') in patients with hepatocellular carcinoma",
keywords = "Chemotherapy, Hepatocellular carcinoma, Raltitrexed, Tomudex, Treatment outcome",
author = "P. Rougier and M. Ducreux and D. Kerr and Carr, {B. I.} and E. Fran{\cc}ois and A. Adenis and L. Seymour",
year = "1997",
month = "5",
doi = "10.1023/A:1008249328792",
language = "English",
volume = "8",
pages = "500--502",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "NLM (Medline)",
number = "5",

}

TY - JOUR

T1 - A phase II study of raltitrexed ('Tomudex') in patients with hepatocellular carcinoma

AU - Rougier, P.

AU - Ducreux, M.

AU - Kerr, D.

AU - Carr, B. I.

AU - François, E.

AU - Adenis, A.

AU - Seymour, L.

PY - 1997/5

Y1 - 1997/5

KW - Chemotherapy

KW - Hepatocellular carcinoma

KW - Raltitrexed

KW - Tomudex

KW - Treatment outcome

UR - http://www.scopus.com/inward/record.url?scp=0030805676&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030805676&partnerID=8YFLogxK

U2 - 10.1023/A:1008249328792

DO - 10.1023/A:1008249328792

M3 - Article

C2 - 9233532

AN - SCOPUS:0030805676

VL - 8

SP - 500

EP - 502

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 5

ER -